Literature DB >> 2804134

Direct determination of creatine kinase equilibrium constants with creatine or cyclocreatine substrate.

P LoPresti1, M Cohn.   

Abstract

The equilibrium constants of two reactions catalyzed by rabbit muscle creatine kinase with creatine or cyclocreatine as substrate were determined by 31P-NMR. The value of the equilibrium constant with creatine as substrate was 172.10(7) M(-1) in agreement with previous work (Veech, R.L., Lawson, J.W.R., Cornell, W. and Krebs, H.A. (1979) J. Biol. Chem 254, 6538-6547). The value with cyclocreatine was 5.62.10(7) M(-1) and the ratio of the two constants is 30.6. It was possible to determine the ratio of the two equilibrium constants in a reaction mixture containing both substrates since it was found that the 31P resonances of P-creatine and P-cyclocreatine were well resolved. The ratio of K1/K2 determined in such experiments was 34.6, of the same order as previously reported by Annesley and Walker (Annesley, T.M. and Walker, J.B. (1977) Biochem. Biophys. Res. Commun. 74, 185-190).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2804134     DOI: 10.1016/0167-4838(89)90291-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Cyclocreatine treatment improves cognition in mice with creatine transporter deficiency.

Authors:  Yuko Kurosawa; Ton J Degrauw; Diana M Lindquist; Victor M Blanco; Gail J Pyne-Geithman; Takiko Daikoku; James B Chambers; Stephen C Benoit; Joseph F Clark
Journal:  J Clin Invest       Date:  2012-07-02       Impact factor: 14.808

2.  Inhibition of rate of tumor growth by creatine and cyclocreatine.

Authors:  E E Miller; A E Evans; M Cohn
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

3.  In vivo detection of gene expression in liver by 31P nuclear magnetic resonance spectroscopy employing creatine kinase as a marker gene.

Authors:  A Auricchio; R Zhou; J M Wilson; J D Glickson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

4.  Phosphocyclocreatine is the dominant form of cyclocreatine in control and creatine transporter deficiency patient fibroblasts.

Authors:  Kirill Gorshkov; Amy Q Wang; Wei Sun; Ethan Fisher; Marta Frigeni; Marc Singleton; Natasha Thorne; Bradley Class; Wenwei Huang; Nicola Longo; Minh-Ha T Do; Elizabeth A Ottinger; Xin Xu; Wei Zheng
Journal:  Pharmacol Res Perspect       Date:  2019-12

5.  Creatine and cyclocreatine treatment of human colon adenocarcinoma xenografts: 31P and 1H magnetic resonance spectroscopic studies.

Authors:  C A Kristensen; N Askenasy; R K Jain; A P Koretsky
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

6.  Creatine salts provide neuroprotection even after partial impairment of the creatine transporter.

Authors:  E Adriano; P Garbati; A Salis; G Damonte; E Millo; M Balestrino
Journal:  Neuroscience       Date:  2016-02-27       Impact factor: 3.590

Review 7.  The Creatine Transporter Unfolded: A Knotty Premise in the Cerebral Creatine Deficiency Syndrome.

Authors:  Clemens V Farr; Ali El-Kasaby; Michael Freissmuth; Sonja Sucic
Journal:  Front Synaptic Neurosci       Date:  2020-10-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.